Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study. - Wikidata - awgldk - TriplyDB

Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study.

Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study.

http://www.wikidata.org/entity/Q34068661

about

Management of bleeding and coagulopathy following major trauma: an updated European guideline.The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition Preoperative factors associated with red blood cell transfusion in hip fracture patients.Evaluation of platelet function using PFA-100® in patients treated with Acetylsalicylic acid and qualified for Trauma and Orthopedic surgery procedures.The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects.

P2860

Q21092902-8F8A7ACC-7E14-4219-8F09-7A9B1C1B568A Q27339343-93215D6B-F427-41ED-A200-00E6F4D2747B Q38171287-36AB9B56-BF49-44E7-BA70-D3DA6991D1F7 Q39839175-8B85E83F-D3FE-45A5-AF50-2A3BCF35229F Q47936752-51A48CEB-DAEB-4985-8781-94C72DE19413

P2860

Bleeding and first-year mortality following hip fracture surgery and preoperative use of low-dose acetylsalicylic acid: an observational cohort study.

http://www.wikidata.org/entity/Q34068661

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Bleeding and first-year mortal ...... an observational cohort study.

@ast

Bleeding and first-year mortal ...... an observational cohort study.

@en

Bleeding and first-year mortal ...... an observational cohort study.

@nl

type

label

Bleeding and first-year mortal ...... an observational cohort study.

@ast

Bleeding and first-year mortal ...... an observational cohort study.

@en

Bleeding and first-year mortal ...... an observational cohort study.

@nl

prefLabel

Bleeding and first-year mortal ...... an observational cohort study.

@ast

Bleeding and first-year mortal ...... an observational cohort study.

@en

Bleeding and first-year mortal ...... an observational cohort study.

@nl

P1433

Q34068661-F0BE39D8-D794-42DD-8FEA-F7AD8226AB21

P1476

Q34068661-71484AA5-46F8-4997-9F97-4B2F55964C18

P2093

Q34068661-1C92C716-26F8-4774-9E2C-5DE268B949D3

Q34068661-2F7AFEC7-7B71-4400-BB42-78C2BF246B31

Q34068661-5FBC49EE-A49F-497B-A949-2F81A92FB20D

Q34068661-74547A0C-F212-481C-A403-32FC7AAF9A99

Q34068661-C7515300-86A9-4752-B98B-4FC84ED172FA

P2860

Q34068661-26DD3E58-B8BF-40AB-BFD5-3BF8242B802C

Q34068661-2BD57D2C-AFC1-4C09-BB76-7009A9833F76

Q34068661-39A48EA7-30FF-48AE-8F62-DCFFDEF6F24A

Q34068661-3E63D02B-F898-4543-85A8-33DCE51BF648

Q34068661-451CE988-2585-4736-9BD3-B29388A09F08

Q34068661-46B75A8B-CB8C-42FA-8978-9C07E7A54FDC

Q34068661-4A24AFA3-8FCF-4C46-8FAA-C6A04E94B832

Q34068661-4E361FF4-41B4-4148-B80B-96591E735F9D

Q34068661-58A6997E-2E50-44D0-9F1C-33E72FE531B2

Q34068661-67C58FEF-95FD-4C67-874B-93DF99E2A47B

P2888

Q34068661-49E71C6C-EB9D-4A1C-AD63-23391B620EE3

P304

Q34068661-C2C765C7-9502-4C7D-BC0E-EA42B76A79D2

P31

Q34068661-078BD9ED-C831-4DEF-802B-5113C89B4051

P356

Q34068661-B3018B7B-5885-4255-86CF-2C01565D3723

P478

Q34068661-F823F0D0-921C-48AF-AEB2-13A1915210F7

P577

Q34068661-EA923EA3-F497-41A1-AA27-AF87A7647590

P5875

Q34068661-17C6FDA7-FCB3-4D99-93ED-2B11CBDAEEE6

P6179

Q34068661-A46AEE65-CBC9-46CA-8E74-B80168E05B38

P698

Q34068661-DB552DA0-ED97-4944-AD62-05C1BC71637E

P932

Q34068661-B25720BD-E292-4FF2-B9AB-CF654F785D1F

P356

1471-2474-12-254

P1433

BMC Musculoskeletal Disorders

P1476

Bleeding and first-year mortal ...... an observational cohort study.

@en

P2093

Anna Apelqvist

http://www.w3.org/2001/XMLSchema#string

Annika M Kragh

http://www.w3.org/2001/XMLSchema#string

Isam Atroshi

http://www.w3.org/2001/XMLSchema#string

Markus Waldén

http://www.w3.org/2001/XMLSchema#string

Philippe Wagner

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study

The effect of aspirin on blood loss and transfusion requirements in patients with femoral neck fractures

Aspirin therapy and bleeding during proximal femoral fracture surgery

Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis

Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases

The association between aspirin and blood loss in hip fracture patients

Aspirin dose for the prevention of cardiovascular disease: a systematic review

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction

Perioperative use of anti-platelet drugs

Early mortality after surgical fixation of hip fractures in the elderly: an analysis of data from the scottish hip fracture audit.

P2888

1471-2474-12-254

P304

254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2474-12-254

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51779971

http://www.w3.org/2001/XMLSchema#string

P6179

1038326233

http://www.w3.org/2001/XMLSchema#string

P698

22059476

http://www.w3.org/2001/XMLSchema#string

P932

3220640

http://www.w3.org/2001/XMLSchema#string